Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis

Journal of Ethnopharmacology

Volumn 126, Issue 1, 2009, Pages 143-148

  Zhou, Xian Mei ^a   Huang, Min Min ^a   He, Cui Cui ^b   Li, Jian Xin ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Bleomycin; Citrus reticulata; Ethanol extract; Pulmonary fibrosis; Transforming growth factor 1

Indexed keywords

ALCOHOL; BLEOMYCIN; HYDROXYPROLINE; MANDARIN EXTRACT; MESSENGER RNA; PLANT EXTRACT; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG SCREENING; EMBRYO; FIBROBLAST CULTURE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LUNG ALVEOLITIS; LUNG FIBROBLAST; LUNG FIBROSIS; MALE; MANDARIN; MEDICAL RESEARCH; NONHUMAN; PERICARP; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; WEIGHT GAIN;

ANIMALS; BLEOMYCIN; BODY WEIGHT; CELL SURVIVAL; CELLS, CULTURED; CITRUS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HYDROXYPROLINE; LUNG; MALE; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

CITRUS; CITRUS RETICULATA; RATTUS;

EID: 70349758086     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.07.025     Document Type: Article

References (26)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment-international consensus statement. American Journal of Respiratory and Critical Care Medicine 161 (2000) 646-664
2. American Thoracic Society. ATS/ERS international consensus classification of idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine 165 (2002) 277-304
3. Andersson-Sjöland A., de Alba C.G., Nihlberg K., Becerril C., Ramírez R., Pardo A., Westergren-Thorsson G., and Selman M. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. The International Journal of Biochemistry and Cell Biology 40 (2008) 2129-2140
4. Benavente-García O., and Castillo J. Update on uses and properties of Citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. Journal of Agricultural and Food Chemistry 56 (2008) 6185-6205
5. Cano A., Medina A., and Bermejo A. Bioactive compounds in different citrus varieties. Discrimination among cultivars. Journal of Food Composition and Analysis 21 (2008) 377-381
6. 1 targets the GSK-3β/β-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacological Research 57 (2008) 274-282
7. China Pharmacopoeia Committee. Chinese Pharmacopeia (2005), Chemical Industry Press, Beijing, China
8. Editorial board of Chinese Materia Medica. Chinese Materia Medica (1996), Shanghai Scientific & Technical Publishers, Shanghai, China
9. Flaherty K.R., Toews G.B., Lynch J.P., Kazerooni E.A., Gross B.H., Strawderman R.L., Hariharan K., Flint A., and Martinez F.J. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. American Journal of Medicine 110 (2001) 278-282
10. Guo H.Y., and Zhou X.M. Effects of Hu-qi-yin on proliferation and apoptosis of human embryonic lung fibroblast cells. Medicine and Clinical Research of China 14 (2008) 1-4
11. Ho S.C., and Lin C.C. Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. Journal of Agricultural and Food Chemistry 56 (2008) 7976-7982
12. Jeon K., Chung M.P., Lee K.S., Chung M.J., Han J., Koh W.J., Suh G.Y., Kim H., and Kwon O.J. Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis. Respiratory Medicine 100 (2006) 451-457
13. Kohyama T., Yamauchi Y., Takizawa H., Itakura S., Kamitani S., Kato J., and Nagase T. Clarithromycin inhibits fibroblast migration. Respiratory Medicine 102 (2008) 1769-1776
14. Maher T.M., Wells A.U., and Laurent G.J. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?. European Respiratory Journal 30 (2007) 835-839
15. Mallick S. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respiratory Medicine 102 (2008) 1355-1359
16. Martin G.E.M., Ask K., Gilpin S.E., Kolb M., and Gauldie J. The transforming growth factor-beta (TGF-β) family and pulmonary fibrosis. Drug Discovery Today: Disease Mechanisms 3 (2006) 99-103
17. Mathai S.C., and Polito A.J. The questionable efficacy of pirfenidone in IPF. American Journal of Respiratory and Critical Care Medicine 172 (2005) 1228
18. Moeller A., Ask K., Warburton D., Gauldie J., and Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. The International Journal of Biochemistry and Cell Biology 40 (2008) 362-382
19. Raghu G., Depaso W.J., Cain K., Hammar S.P., Wetzel C.E., Dreis D.F., Hutchinson J., Pardee N., and Winterbauer R.H. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. American Review of Respiratory Disease 144 (1991) 291-296
20. Selman M., Carrillo G., Salas J., Padilla R.P., Perez-Chavira R., and Sansores R. Colchicine, d-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. Chest 114 (1998) 507-512
21. Sener G., Topaloglu N., Sehirli A.O., Ercan F., and Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulmonary Pharmacology & Therapeutics 20 (2007) 642-649
22. Szapiel S.V., Elson N.A., Fulmer J.D., Hunninghake G.W., and Crystal R.G. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. American Review of Respiratory Disease 120 (1979) 893-899
23. Usuki K., and Fukuda Y. Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathology International 45 (1995) 552-564
24. White E.S., Atrasz R.G., Hu B., Phan S.H., Stambolic V., Mak T.W., Hogaboam C.M., Flaherty K.R., Martinez F.J., Kontos C.D., and Toews G.B. Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). American Journal of Respiratory and Critical Care Medicine 173 (2006) 112-121
25. Zhang L., Zhang D.Y., Liu Y.L., Luo J., and Dun Z. Determination of total flavonoids and luteolin in traditional Tibetan drug Pyrethrum tatsienense (Bur. et Franch.) Lin. Chinese Journal of Pharmaceutical Analysis 28 (2008) 755-758
26. Zhou X.M., Zhang G.C., Li J.X., and Hou J. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats. Journal of Ethnopharmacology 111 (2007) 255-264